Prudential Financial
CGEM icon

Prudential Financial’s Cullinan Oncology CGEM Stock Holding History

Prudential Financial’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.05M Buy
167,555
+18,110
+12% +$269K ﹤0.01% 1231
2026
Q1 		$2.12M Buy
+149,445
New +$1.92M ﹤0.01% 1292
2024
Q2 		– Sell
-20,225
Closed -$345K – 2714
2024
Q1 		$345K Sell
20,225
-19,900
-50% -$307K ﹤0.01% 2290
2023
Q4 		$409K Buy
40,125
+4,560
+13% +$40.4K ﹤0.01% 2210
2023
Q3 		$322K Hold
35,565
– – ﹤0.01% 2240
2023
Q2 		$383K Buy
+35,565
New +$378K ﹤0.01% 2219

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Prudential Financial's CGEM Position: Q2 2026 in Review

Prudential Financial increased its Cullinan Oncology (CGEM) stake by 12% in Q2 2026, buying an estimated $269K and bringing the position to 167,555 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1231.

Prudential Financial first reported a position in CGEM in Q2 2023 and has held it in 6 quarters since. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Prudential Financial held 167,555 shares of Cullinan Oncology worth $3.05M as of Q2 2026.
  • Prudential Financial bought 18,110 Cullinan Oncology shares in Q2 2026, an estimated $269K.
  • Cullinan Oncology made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1231 holding.
  • Prudential Financial first reported a position in Cullinan Oncology in Q2 2023 and has held it in 6 quarters since.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.